Analysis of the Global Infectious Disease Diagnostics Market

Molecular Methods Present Significant Opportunities

Regular Price: USD 3,950

Special Price USD 3,555

10% OFF

* Required Fields

Regular Price: USD 3,950

Special Price USD 3,555

PAY BY INVOICE

Be the first to review this product

This deliverable provides research and analysis of the global infectious disease diagnostics market. It includes an in-depth analysis of revenue forecast by segment, drivers and restraints, and technology trends, along with the competitive factors and strategies, and key companies to watch. The global market is primarily driven by the high prevalence of these diseases and the growing demand for rapid diagnostic tests. Regional breakdowns are provided for three market segments: immunodiagnostics, molecular methods, and clinical microbiology. Regional breakdowns by disease also are provided. The base year for the study is 2013; the forecast period is from 2014 to 2018.

Table of Contents

Executive SummaryKey FindingsKey Findings (continued)Scope and SegmentationTop Diseases by RegionDiseases and Available Solutions in the Global MarketKey Questions This Study Will AnswerMarket Engineering MeasurementsCEO’s PerspectiveKey Companies to WatchExecutive Summary—3 Big PredictionsMarket OverviewMarket Background—Infectious DiseasesDisease Background—SepsisDisease Background—TBDisease Background—MRSADisease Background—Hepatitis B and CDisease Background—Hepatitis B and C (continued)Disease Background—HantavirusMarket Segmentation—DefinitionsMarket SegmentationHealthcare TrendsCompetitive PlaybookSolutions Provided for Each Disease New Market OpportunitiesNew Market Opportunities (continued)New Market Opportunities (continued)Merger, Acquisition, and Partnership AssessmentMerger, Acquisition, and Partnership Assessment (continued)Merger, Acquisition, and Partnership Assessment (continued)Drivers, Restraints, and Trends—Total Infectious Disease Diagnostics MarketMarket DriversMarket RestraintsForecast and Trends—Total Infectious Disease Diagnostics MarketMarket Engineering MeasurementsForecast Assumptions and DefinitionsRevenue ForecastRevenue Forecast DiscussionPercent Revenue Forecast by RegionRevenue Forecast by RegionPercent Revenue Forecast by SegmentRevenue Forecast by SegmentRevenue Forecast by Segment DiscussionRevenue Forecast by Segment Discussion (continued)Revenue Forecast by Segment Discussion (continued)Segment Lifecycle AnalysisCompetitive EnvironmentCompetitive EnvironmentMarketed Product Analysis—TB Marketed Product Analysis—TB (continued)Marketed Product Analysis—SepsisMarketed Product Analysis—MRSAMarketed Product Analysis—Hepatitis B/CMarketed Product Analysis—Hepatitis B/C (continued)Top CompetitorsTop Competitors (continued)Top Competitors (continued)US Market AnalysisMarket Engineering MeasurementsRevenue ForecastRevenue Forecast by DiseaseRevenue Forecast DiscussionRevenue Forecast by SegmentRevenue Forecast by Segment DiscussionRevenue Forecast by Segment Discussion (continued)Revenue Forecast by Segment Discussion (continued)US—Market AnalysisPESTLE AnalysisMarket Impact of Top TrendsUS—Market Share by TierUS—Tier AnalysisUS—Tier Analysis (continued)US—Tier Analysis (continued)Western Europe Market AnalysisMarket Engineering MeasurementsRevenue ForecastRevenue Forecast by DiseaseRevenue Forecast DiscussionRevenue Forecast by SegmentRevenue Forecast by Segment DiscussionRevenue Forecast by Segment Discussion (continued)Revenue Forecast by Segment Discussion (continued)PESTLE AnalysisMarket Impact of Top TrendsWestern Europe—Market AnalysisWestern Europe—Market Share by TierWestern Europe—Tier AnalysisWestern Europe—Tier Analysis (continued)Western Europe—Tier Analysis (continued)APAC & ROW Market AnalysisMarket Engineering MeasurementsRevenue ForecastRevenue Forecast DiscussionRevenue Forecast by SegmentRevenue Forecast by Segment DiscussionRevenue Forecast by Segment Discussion (continued)Revenue Forecast by Segment Discussion (continued)PESTLE AnalysisMarket Impact of Top TrendsAPAC & ROW—Market AnalysisAPAC & ROW—Market Share by TierAPAC & ROW—Tier AnalysisAPAC & ROW—Tier AnalysisKey Companies to WatchReagenaNanomixAnagnostics GmbHThe Last WordThe Last Word—3 Big PredictionsThe Last Word—DiscussionThe Last Word—Discussion (continued)The Last Word—Discussion (continued)Legal DisclaimerAppendixDrivers ExplainedDrivers Explained (continued)Restraints ExplainedRestraints Explained (continued)Restraints Explained (continued) List of Other Companies—United StatesList of Other Companies—Western EuropeList of Other Companies—APAC and ROWAssociated MultimediaAssociated Multimedia (continued)Market Engineering MethodologyList of ExhibitsList of Exhibits (continued)List of Exhibits (continued)List of Exhibits (continued)




Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.